| 摘要 |
The present invention relates to the use of diacylglycerol kinase delta (DGKdelta) in methods for the identification of pharmaceutically useful agents, in particular agents useful for increasing insulin-stimulated glucose uptake in a mammalian cell and for the treatment or prophylaxis of diabetes. |
